Literature DB >> 7847862

Differentiation of multiple system atrophy from idiopathic Parkinson's disease using proton magnetic resonance spectroscopy.

C A Davie1, G K Wenning, G J Barker, P S Tofts, B E Kendall, N Quinn, W I McDonald, C D Marsden, D H Miller.   

Abstract

Proton magnetic resonance spectroscopy, localized to the lentiform nucleus, was carried out in 7 patients with the pure or predominantly striatonigral variant (SND) of multiple system atrophy (MSA), 5 patients with the olivopontocerebellar variant of MSA, 9 patients with a clinical diagnosis of idiopathic Parkinson's disease (IPD), and 9 healthy age-matched controls. The MSA group with predominantly striatonigral involvement showed a significant reduction in the N-acetylaspartate (NAA)/creatine ratio (median, 1.19; range, 0.96-2.0; p < 0.02) compared with the NAA/creatine ratio from the control group (median, 1.76; range, 1.61-2.0). In contrast, the IPD group had a normal NAA/creatine ratio (median, 1.82; range, 1.19-2.31; p > 0.05). The NAA/creatine ratio was markedly reduced in 6 of the SND patients and in only 1 IPD patient. The choline/creatine ratio was also significantly lower in the SND group (median, 1.02; range, 0.91-1.23; p < 0.04) compared with the control group (median, 1.22; range, 1.05-1.65). The IPD group showed a normal lentiform choline/creatine ratio (median, 1.13; range, 0.89-1.65; p = 0.25) compared with controls. The olivopontocerebellar group also showed a significant reduction in the NAA/creatine ratio from the lentiform nucleus (median, 1.47; range, 1.22-1.68; p < 0.01) compared with the controls as well as a nonsignificant reduction in the choline/creatine ratio (median, 0.93; range, 0.85-1.27; p < 0.4).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7847862     DOI: 10.1002/ana.410370211

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  23 in total

Review 1.  Multiple system atrophy: pathophysiology and management.

Authors:  G K Wenning; S Braune
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 2.  How to diagnose MSA early: the role of magnetic resonance imaging.

Authors:  K Seppi; M F H Schocke; G K Wenning; W Poewe
Journal:  J Neural Transm (Vienna)       Date:  2005-07-06       Impact factor: 3.575

3.  Metabolic changes detected by ex vivo high resolution 1H NMR spectroscopy in the striatum of 6-OHDA-induced Parkinson's rat.

Authors:  Hong-Chang Gao; Huan Zhu; Cai-Yong Song; Li Lin; Yun Xiang; Zhi-Han Yan; Guang-Hui Bai; Fa-Qing Ye; Xiao-Kun Li
Journal:  Mol Neurobiol       Date:  2012-08-31       Impact factor: 5.590

4.  Utility of susceptibility-weighted MRI in differentiating Parkinson's disease and atypical parkinsonism.

Authors:  Deepak Gupta; Jitender Saini; Chandrasekharan Kesavadas; P Sankara Sarma; Asha Kishore
Journal:  Neuroradiology       Date:  2010-04-01       Impact factor: 2.804

5.  Localised 1H-MR spectroscopy for metabolic characterisation of diffuse and focal brain lesions in patients infected with HIV.

Authors:  I L Simone; F Federico; C Tortorella; C F Andreula; G B Zimatore; P Giannini; G Angarano; V Lucivero; P Picciola; D Carrara; A Bellacosa; P Livrea
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-04       Impact factor: 10.154

6.  The nonspecific nature of proton spectroscopy in brain masses in children: a series of demyelinating lesions.

Authors:  H G Pandya; I D Wilkinson; S K Agarwal; P D Griffiths
Journal:  Neuroradiology       Date:  2005-03-18       Impact factor: 2.804

7.  The classification and nomenclature of autonomic disorders--ending chaos, resolving conflict and hopefully achieving clarity.

Authors:  C J Mathias
Journal:  Clin Auton Res       Date:  1995-12       Impact factor: 4.435

8.  Magnetic resonance spectroscopic study of parkinsonism related to boxing.

Authors:  K R Chaudhuri; G Lemmens; S C Williams; P N Leigh
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-11       Impact factor: 10.154

Review 9.  Magnetic resonance imaging and magnetic resonance spectroscopy in dementias.

Authors:  Y Y Hsu; A T Du; N Schuff; M W Weiner
Journal:  J Geriatr Psychiatry Neurol       Date:  2001       Impact factor: 2.680

10.  Metabolic alterations in Parkinson's disease after thalamotomy, as revealed by 1H MR spectroscopy.

Authors:  Hyun-Man Baik; Bo-Young Choe; Hyoung-Koo Lee; Tae-Suk Suh; Byung-Chul Son; Jae-Mun Lee
Journal:  Korean J Radiol       Date:  2002 Jul-Sep       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.